Abstract:Abstract Minimally invasive esophagectomy is increasingly performed for esophageal squamous carcinoma, with advantages of improved perioperative outcomes in comparison with open esophagectomy. Lymph node dissection is one of most important prognostic factors, in esophageal squamous cell carcinoma. It is still unknown whether MIE can meet the criteria of lymph node dissection in the mediastinum, especially in T1 and T2 esophageal cancer. Here, we compared the lymph node dissection between MIE and open surgery. Methods We retrospectively reviewed the clinicopathological data from 147 patients who underwent open surgery and MIE for esophageal squamous cell carcinoma from December 2016 to January 2020. The clinicopathological data including age, gender, number of lymph node resected were analyzed. Results 68 patients underwent MIE and 79 patients underwent open surgery. The number of harvested lymph node didn’t differ between the open surgery group and MIE group (26 ± 11.9 vs 26 ± 13.4, respectively, p = 0.128). However, the number of resected lymph node in the low para-esophageal region was significantly higher in open surgery group (4.1 ± 3.9 vs 2.8 ± 2.6, respectively, p = 0.019). The number of resected lymph node in the upper mediastinal region was significantly higher in the MIE group in T1 and T2 patients (4.7 ± 3.8 vs 2.7 ± 2.9, respectively, p = 0.014). the difference was also noticed in the para-recurrent laryngeal lymph node regions (3.6 ± 2.9 vs 2.0 ± 2.3, respectively, p = 0.020). Conclusion For stages T1 and T2 esophageal squamous cell carcinoma, the lymph node dissection by MIE was comparable to that by open surgery. However, the number of harvested lymph node in the upper mediastinal region was better in the MIE group, which may indicate a better outcome. There was no difference in the postoperative complications, hospital stay and overall survival rate.

Advances in the Surgical Management of Esophageal Cancer

254 lymph node dissection in t1 and t2 esophageal squamous cell carcinoma: minimally invasive esophagectomy versus open surgery

Short-term Clinical Efficacies of Esophageal Carcinoma Treated Surgically by Ivor-Lewis Approach

696 LONG-TERM OUTCOMES OF MINIMALLY INVASIVE ESOPHAGECTOMY COMPARED TO OPEN ESOPHAGECTOMY: A RETROSPECTIVE ANALYSIS OF 2958 CASES IN SINGLE CANCER CENTER

Advances in diagnosis and management of cancer of the esophagus

Current Status and Future Prospects for Esophageal Cancer Treatment

Role of endoscopic therapy in early esophageal cancer

Prevention and management of early esophageal cancer

Recent progress in multidisciplinary treatment for patients with esophageal cancer

Single-Position, Minimally Invasive Ivor Lewis Oesophagectomy For Lower Thoracic Oesophageal Cancer

Milestones in the History of Esophagectomy: From Torek to Minimally Invasive Approaches

Minimally Invasive Esophagectomy Via Sweet Approach in Combination with Cervical Mediastinoscopy for Esophageal Squamous Cell Carcinoma: a Case Series

Totally Minimally Invasive Ivor-Lewis Esophagectomy with Single-Utility Incision Video-Assisted Thoracoscopic Surgery for Treatment of Mid-Lower Esophageal Cancer.

Application of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy in Individualized Treatment of Esophageal Cancer

Endoscopic Surgery of Esophageal Cancer

Endoscopic Therapies for Early Stage Esophageal and Gastric Cancers

[Minimally Invasive Esophagectomy for Esophageal Carcinoma: Clinical Analysis of 160 Cases].

Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation

Minimally Invasive Esophagectomy Provides Better Short- and Long-Term Outcomes Than Open Esophagectomy in Locally Advanced Esophageal Cancer

Minimally Invasive Esophageal Resection and Intrathoracic Anastomosis for Lower Thoracic Esophageal Cancer with Single Position.

Surgical Technique and Implementation of Total Minimally Invasive (Laparo-Thoracoscopic) Ivor Lewis Esophagectomy for Cancer